{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T18:11:57Z","timestamp":1794507117481,"version":"4.9.1"},"reference-count":75,"publisher":"Bentham Science Publishers Ltd.","issue":"10","funder":[{"DOI":"10.13039\/501100001501","name":"University Grant Commission","doi-asserted-by":"publisher","award":["324892"],"award-info":[{"award-number":["324892"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CNSNDDT"],"published-print":{"date-parts":[[2021,1,27]]},"abstract":"<jats:sec>\n<jats:title> Background:<\/jats:title>\n<jats:p> Tremor is one of the most noticeable features, which occurs during the early\nstages of Parkinson\u2019s Disease (PD). It is one of the major pathological hallmarks and does not\nhave any interpreted mechanism. In this study, we have framed a hypothesis and deciphered protein-\nprotein interactions between the proteins involved in impairment in sodium and calcium ion\nchannels and thus cause synaptic plasticity leading to a tremor.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Literature mining for retrieval of proteins was done using Science Direct, PubMed Central,\nSciELO and JSTOR databases. A well-thought approach was used, and a list of differentially\nexpressed proteins in PD was collected from different sources. A total of 71 proteins were retrieved,\nand a protein interaction network was constructed between them by using Cytoscape.v.3.7.\nThe network was further analysed using the BiNGO plugin for retrieval of overrepresented biological\nprocesses in Tremor-PD datasets. Hub nodes were also generated in the network.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The Tremor-PD pathway was deciphered, which demonstrates the cascade of protein interactions\nthat might lead to tremors in PD. Major proteins involved were LRRK2, TUBA1A,\nTRAF6, HSPA5, ADORA2A, DRD1, DRD2, SNCA, ADCY5, TH, etc.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p> In the current study, it is predicted that ADORA2A and DRD1\/DRD2 are equally contributing\nto the progression of the disease by inhibiting the activity of adenylyl cyclase and thereby\nincreases the permeability of the blood-brain barrier, causing an influx of neurotransmitters and together\nthey alter the level of dopamine in the brain which eventually leads to tremor.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871527319666200905115548","type":"journal-article","created":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T11:47:04Z","timestamp":1599306424000},"page":"780-790","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Protein Interaction Studies for Understanding the Tremor Pathway in Parkinson\u2019s Disease"],"prefix":"10.2174","volume":"19","author":[{"given":"Nitu","family":"Dogra","sequence":"first","affiliation":[{"name":"Proteomics and Translational Research Lab, Centre for Medical Biotechnology, Amity Institute of Biotechnology, Amity University, Noida 201301, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchi Jakhmola","family":"Mani","sequence":"additional","affiliation":[{"name":"Proteomics and Translational Research Lab, Centre for Medical Biotechnology, Amity Institute of Biotechnology, Amity University, Noida 201301, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepshikha Pande","family":"Katare","sequence":"additional","affiliation":[{"name":"Proteomics and Translational Research Lab, Centre for Medical Biotechnology, Amity Institute of Biotechnology, Amity University, Noida 201301, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.31887\/DCNS.2004.6.3\/galexander","volume":"6","author":"Alexander G.E.","year":"2004","unstructured":"Alexander G.E.; Biology of Parkinson\u2019s disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder. Dialogues Clin Neurosci 2004,6(3),259-280","journal-title":"Dialogues Clin Neurosci"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"232","DOI":"10.4103\/0976-3147.176192","volume":"7","author":"Qayyum R.A","year":"2016","unstructured":"Qayyum R.A; Mohamad S.; Relationship between resting and action tremors in Parkinson's disease. J Neurosci Rural Pract 2016,7(2),232-237","journal-title":"J Neurosci Rural Pract"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.cmet.2012.08.012","volume":"16","author":"Mattson M.P.","year":"2012","unstructured":"Mattson M.P.; Energy intake and exercise as determinants of brain health and vulnerability to injury and disease. Cell Metab 2012,16(6),706-722","journal-title":"Cell Metab"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"9832839","DOI":"10.1155\/2016\/9832839","volume":"2016","author":"Magrinelli F","year":"2016","unstructured":"Magrinelli F; Picelli A; Tocco P; Pathophysiology of motor dysfunction in Parkinson\u2019s disease as the rationale for drug treatment and rehabilitation. Parkinsons Dis 2016,2016,9832839","journal-title":"Parkinsons Dis"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1093\/brain\/aws023","volume":"135","author":"Helmich R.C.","year":"2012","unstructured":"Helmich R.C.; Hallett M.; Deuschl G.; Toni I.; Bloem B.R.; Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits? Brain 2012,135(Pt 11),3206-3226","journal-title":"Brain"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jns.2016.04.041","volume":"366","author":"Mailankody P.","year":"2016","unstructured":"Mailankody P.; Thennarasu K.; Nagaraju B.C.; Yadav R.; Pal P.K.; Re-emergent tremor in Parkinson\u2019s disease: A clinical and electromyographic study. J Neurol Sci 2016,366,33-36","journal-title":"J Neurol Sci"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1586\/14737175.2014.877842","volume":"14","author":"Jellinger K.A.","year":"2014","unstructured":"Jellinger K.A.; The pathomechanisms underlying Parkinson\u2019s disease. Expert Rev Neurother 2014,14(2),199-215","journal-title":"Expert Rev Neurother"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"706","DOI":"10.4161\/auto.5.5.8505","volume":"5","author":"Narendra D.","year":"2009","unstructured":"Narendra D.; Tanaka A.; Suen D.F.; Youle R.J.; Parkin-induced mitophagy in the pathogenesis of Parkinson disease. Autophagy 2009,5(5),706-708","journal-title":"Autophagy"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1016\/j.neurobiolaging.2008.11.008","volume":"31","author":"Tan E.K.","year":"2010","unstructured":"Tan E.K.; Lu C.S.; Peng R.; Teo Y.Y.; Wu-Chou Y.H.; Chen R.S.; Weng Y.H.; Chen C.M.; Fung H.C.; Tan L.C.; Zhang Z.J.; An X.K.; Lee-Chen G.J.; Lee M.C.; Fook-Chong S.; Burgunder J.M.; Wu R.M.; Wu Y.R.; Analysis of the UCHL1 genetic variant in Parkinson\u2019s disease among Chinese. Neurobiol Aging 2010,31(12),2194-2196","journal-title":"Neurobiol Aging"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/ana.20256","volume":"56","author":"Valente E.M.","year":"2004","unstructured":"Valente E.M.; Salvi S.; Ialongo T.; Marongiu R.; Elia A.E.; Caputo V.; Romito L.; Albanese A.; Dallapiccola B.; Bentivoglio A.R.; PINK1 mutations are associated with sporadic early-onset parkinsonism. Ann Neurol 2004,56(3),336-341","journal-title":"Ann Neurol"},{"key":"ref=11","first-page":"281","volume":"25","author":"Tarantino P.","year":"2004","unstructured":"Tarantino P.; Annesi G.; Annesi F.; Nicoletti G.; Morgante L.; Savettieri G.; Manobianca G.; Logroscino G.; Epifanio A.; Arabia G.; Civitelli D.; DJ-1 gene in late-onset recessive Parkinson's Disease XXXV Congress of the Italian Neurological Society 2004,25,281-281","journal-title":"XXXV Congress of the Italian Neurological Society"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1242\/dmm.028738","volume":"10","author":"Zaichick S.V.","year":"2017","unstructured":"Zaichick S.V.; McGrath K.M.; Caraveo G.; The role of Ca signaling in Parkinson\u2019s disease. Dis Model Mech 2017,10(5),519-535","journal-title":"Dis Model Mech"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"146","DOI":"10.32607\/20758251-2015-7-4-146-149","volume":"7","author":"Konovalova E.V.","year":"2015","unstructured":"Konovalova E.V.; Lopacheva O.M.; Grivennikov I.A.; Lebedeva O.S.; Dashinimaev E.B.; Khaspekov L.G.; Fedotova E.Y.; Illarioshkin S.N.; Mutations in the Parkinson\u2019s disease-associated PARK2 gene are accompanied by imbalance in programmed cell death systems. Acta Naturae 2015,7(4),146-149","journal-title":"Acta Naturae"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"24475","DOI":"10.1038\/srep24475","volume":"6","author":"Siddiqui I.J.","year":"2016","unstructured":"Siddiqui I.J.; Pervaiz N.; Abbasi A.A.; The Parkinson disease gene SNCA: Evolutionary and structural insights with pathological implication. Sci Rep 2016,6,24475","journal-title":"Sci Rep"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/ane.12181","volume":"129","author":"Casetta I.","year":"2014","unstructured":"Casetta I.; Vincenzi F.; Bencivelli D.; Corciulo C.; Gentile M.; Granieri E.; Borea P.A.; Varani K.; A(2A) adenosine receptors and Parkinson\u2019s disease severity. Acta Neurol Scand 2014,129(4),276-281","journal-title":"Acta Neurol Scand"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3389\/fneur.2018.00109","volume":"9","author":"Erga A.H.","year":"2018","unstructured":"Erga A.H.; Dalen I.; Ushakova A.; Chung J.; Tzoulis C.; Tysnes O.B.; Alves G.; Pedersen K.F.; Maple-Gr\u00f8dem J.; Dopaminergic and opioid pathways associated with impulse control disorders in Parkinson\u2019s disease. Front Neurol 2018,9,109","journal-title":"Front Neurol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.parkreldis.2015.11.016","volume":"22","author":"Hassan A.","year":"2016","unstructured":"Hassan A.; Heckman M.G.; Ahlskog J.E.; Wszolek Z.K.; Serie D.J.; Uitti R.J.; van Gerpen J.A.; Okun M.S.; Rayaprolu S.; Ross O.A.; Association of Parkinson disease age of onset with DRD2, DRD3 and GRIN2B polymorphisms. Parkinsonism Relat Disord 2016,22,102-105","journal-title":"Parkinsonism Relat Disord"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.gendis.2016.04.004","volume":"3","author":"Jayapalan S.","year":"2016","unstructured":"Jayapalan S.; Subramanian D.; Natarajan J.; Computational identification and analysis of neurodegenerative disease associated protein kinases in hominid genomes. Genes Dis 2016,3(3),228-237","journal-title":"Genes Dis"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.neulet.2013.10.060","volume":"564","author":"Zhai D.","year":"2014","unstructured":"Zhai D.; Li S.; Zhao Y.; Lin Z.; SLC6A3 is a risk factor for Parkinson\u2019s disease: a meta-analysis of sixteen years\u2019 studies. Neurosci Lett 2014,564,99-104","journal-title":"Neurosci Lett"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2174\/187152712800792785","volume":"11","author":"Tabrez S","year":"2012","unstructured":"Tabrez S; A synopsis on the role of tyrosine hydroxylase in Parkinson's Disease. CNS  2012,11(4),395-409","journal-title":"CNS"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1186\/s12864-017-4098-3","volume":"18","author":"Chatterjee P.","year":"2017","unstructured":"Chatterjee P.; Roy D.; Bhattacharyya M.; Bandyopadhyay S.; Biological networks in Parkinson\u2019s disease: an insight into the epigenetic mechanisms associated with this disease. BMC Genomics 2017,18(1),721","journal-title":"BMC Genomics"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/mds.26598","volume":"31","author":"Chang F.C.","year":"2016","unstructured":"Chang F.C.; Westenberger A.; Dale R.C.; Smith M.; Pall H.S.; Perez-Due\u00f1as B.; Grattan-Smith P.; Ouvrier R.A.; Mahant N.; Hanna B.C.; Hunter M.; Lawson J.A.; Max C.; Sachdev R.; Meyer E.; Crimmins D.; Pryor D.; Morris J.G.; M\u00fcnchau A.; Grozeva D.; Carss K.J.; Raymond L.; Kurian M.A.; Klein C.; Fung V.S.; Phenotypic insights into ADCY5-associated disease. Mov Disord 2016,31(7),1033-1040","journal-title":"Mov Disord"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"15194","DOI":"10.1074\/jbc.M113.457408","volume":"288","author":"Tanik S.A.","year":"2013","unstructured":"Tanik S.A.; Schultheiss C.E.; Volpicelli-Daley L.A.; Brunden K.R.; Lee V.M.; Lewy body-like \u03b1-synuclein aggregates resist degradation and impair macroautophagy. J Biol Chem 2013,288(21),15194-15210","journal-title":"J Biol Chem"},{"key":"ref=24","first-page":"4813","volume":"14","author":"Chen Y.","year":"2017","unstructured":"Chen Y.; Lian Y.; Ma Y.; Wu C.; Zheng Y.; Xie N.; The expression and significance of tyrosine hydroxylase in the brain tissue of Parkinsons disease rats. Exp Ther Med 2017,14(5),4813-4816","journal-title":"Exp Ther Med"},{"key":"ref=25","first-page":"291","author":"Kohl M.","year":"2011","unstructured":"Kohl M.; Wiese S.; Warscheid B.;  Cytoscape: software for visualization and analysis of biological networks InData Mining in Proteomics 2011,291-303","journal-title":"Cytoscape: software for visualization and analysis of biological networks InData Mining in Proteomics"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.1093\/bioinformatics\/bti551","volume":"21","author":"Maere S.","year":"2005","unstructured":"Maere S.; Heymans K.; Kuiper M.; BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 2005,21(16),3448-3449","journal-title":"Bioinformatics"},{"key":"ref=27","author":"Scardoni G","unstructured":"Scardoni G; TOSADORI G, LAUDANNA C, Fabbri F, FAIZAAAN M. CentiScaPe: Network centralities for Cytoscape"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3389\/fnmol.2016.00089","volume":"9","author":"Le W.","year":"2016","unstructured":"Le W.; Wu J.; Tang Y.; Protective microglia and their regulation in Parkinson\u2019s disease. Front Mol Neurosci 2016,9,89","journal-title":"Front Mol Neurosci"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrn2038","volume":"8","author":"Block M.L.","year":"2007","unstructured":"Block M.L.; Zecca L.; Hong J.S.; Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 2007,8(1),57-69","journal-title":"Nat Rev Neurosci"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s12640-009-9076-3","volume":"16","author":"Shimoji M.","year":"2009","unstructured":"Shimoji M.; Pagan F.; Healton E.B.; Mocchetti I.; CXCR4 and CXCL12 expression is increased in the nigro-striatal system of Parkinson\u2019s disease. Neurotox Res 2009,16(3),318-328","journal-title":"Neurotox Res"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"628192","DOI":"10.1155\/2015\/628192","volume":"2015","author":"Rocha NP","year":"2015","unstructured":"Rocha NP; de Miranda AS; Teixeira AL; Insights into neuroinflammation in Parkinson\u2019s disease: from biomarkers to anti-inflammatory based therapies. Biomed Res Int 2015,2015,628192","journal-title":"Biomed Res Int"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s10571-011-9671-8","volume":"31","author":"Greene L.A.","year":"2011","unstructured":"Greene L.A.; Levy O.; Malagelada C.; Akt as a victim, villain and potential hero in Parkinson\u2019s disease pathophysiology and treatment. Cell Mol Neurobiol 2011,31(7),969-978","journal-title":"Cell Mol Neurobiol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1002\/mds.23851","volume":"26","author":"Kauther K.M.","year":"2011","unstructured":"Kauther K.M.; H\u00f6ft C.; Rissling I.; Oertel W.H.; M\u00f6ller J.C.; The PLA2G6 gene in early-onset Parkinson\u2019s disease. Mov Disord 2011,26(13),2415-2417","journal-title":"Mov Disord"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.ymthe.2018.02.022","volume":"26","author":"Torra A.","year":"2018","unstructured":"Torra A.; Parent A.; Cuadros T.; Overexpression of TFEB drives a pleiotropic neurotrophic effect and prevents Parkinson\u2019s disease-related neurodegeneration. Mol Ther 2018,26(6),1552-1567","journal-title":"Mol Ther"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1002\/1873-3468.12989","volume":"592","author":"Kang I.","year":"2018","unstructured":"Kang I.; Chu C.T.; Kaufman B.A.; The mitochondrial transcription factor TFAM in neurodegeneration: emerging evidence and mechanisms. FEBS Lett 2018,592(5),793-811","journal-title":"FEBS Lett"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"954","DOI":"10.3390\/ijms17060954","volume":"17","author":"Ogino M.","year":"2016","unstructured":"Ogino M.; Ichimura M.; Nakano N.; Minami A.; Kitagishi Y.; Matsuda S.; Roles of PTEN with DNA Repair in Parkinson\u2019s Disease. Int J Mol Sci 2016,17(6),954","journal-title":"Int J Mol Sci"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1093\/hmg\/ddt530","volume":"23","author":"Pino E.","year":"2014","unstructured":"Pino E.; Amamoto R.; Zheng L.; Cacquevel M.; Sarria J.C.; Knott G.W.; Schneider B.L.; FOXO3 determines the accumulation of \u03b1-synuclein and controls the fate of dopaminergic neurons in the substantia nigra. Hum Mol Genet 2014,23(6),1435-1452","journal-title":"Hum Mol Genet"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1523\/JNEUROSCI.21-07-02247.2001","volume":"21","author":"Hartmann A.","year":"2001","unstructured":"Hartmann A.; Troadec J.D.; Hunot S.; Kikly K.; Faucheux B.A.; Mouatt-Prigent A.; Ruberg M.; Agid Y.; Hirsch E.C.; Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson\u2019s disease, but pathway inhibition results in neuronal necrosis. J Neurosci 2001,21(7),2247-2255","journal-title":"J Neurosci"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1016\/j.cellsig.2014.08.019","volume":"26","author":"Heras-Sandoval D.","year":"2014","unstructured":"Heras-Sandoval D.; P\u00e9rez-Rojas J.M.; Hern\u00e1ndez-Dami\u00e1n J.; Pedraza-Chaverri J.; The role of PI3K\/AKT\/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration. Cell Signal 2014,26(12),2694-2701","journal-title":"Cell Signal"},{"key":"ref=40","author":"Qin H","unstructured":"Qin H; Buckley J; Liu Y; Holdbrooks A; Benveniste ET;  Targeting the JAK\/STAT pathway in the treatment of Parkinson\u2019s disease. Available from"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0304-3940(96)12706-3","volume":"211","author":"Mogi M.","year":"1996","unstructured":"Mogi M.; Harada M.; Narabayashi H.; Inagaki H.; Minami M.; Nagatsu T.; Interleukin (IL)-1 \u03b2, IL-2, IL-4, IL-6 and transforming growth factor-\u03b1 levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson\u2019s disease. Neurosci Lett 1996,211(1),13-16","journal-title":"Neurosci Lett"},{"key":"ref=42","first-page":"67","volume":"4","author":"Jha S.K.","year":"2015","unstructured":"Jha S.K.; Jha N.K.; Kar R.; Ambasta R.K.; Kumar P.; p38 MAPK and PI3K\/AKT signalling cascades in Parkinson\u2019s disease. Int J Mol Cell Med 2015,4(2),67-86","journal-title":"Int J Mol Cell Med"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fnagi.2015.00039","volume":"7","author":"Mercado G.","year":"2015","unstructured":"Mercado G.; Castillo V.; Vidal R.; Hetz C.; ER proteostasis disturbances in Parkinson\u2019s disease: novel insights. Front Aging Neurosci 2015,7,39","journal-title":"Front Aging Neurosci"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000351419","volume":"3","author":"Shibata N.","year":"2013","unstructured":"Shibata N.; Motoi Y.; Tomiyama H.; Lack of genetic associations of PPAR-\u03b3 and PGC-1\u03b1 with Alzheimer\u2019s disease and Parkinson\u2019s disease with dementia. Dement Geriatr Cogn Disord Extra 2013,3(1),161-167","journal-title":"Dement Geriatr Cogn Disord Extra"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/S1474-4422(10)70254-4","volume":"9","author":"Marks W.J.","year":"2010","unstructured":"Marks W.J.; Bartus R.T.; Siffert J.; Davis C.S.; Lozano A.; Boulis N.; Vitek J.; Stacy M.; Turner D.; Verhagen L.; Bakay R.; Watts R.; Guthrie B.; Jankovic J.; Simpson R.; Tagliati M.; Alterman R.; Stern M.; Baltuch G.; Starr P.A.; Larson P.S.; Ostrem J.L.; Nutt J.; Kieburtz K.; Kordower J.H.; Olanow C.W.; Gene delivery of AAV2-neurturin for Parkinson\u2019s disease: a double-blind, randomised, controlled trial. Lancet Neurol 2010,9(12),1164-1172","journal-title":"Lancet Neurol"},{"key":"ref=46","first-page":"2","volume":"8","author":"Perez A.","year":"2016","unstructured":"Perez A.; Guan L.; Sutherland K.; Cao C.; Immune system and Parkinson\u2019s disease. Arch Med 2016,8,2","journal-title":"Arch Med"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s11064-011-0637-5","volume":"37","author":"Thenral S.T.","year":"2012","unstructured":"Thenral S.T.; Vanisree A.J.; Peripheral assessment of the genes AQP4, PBP and TH in patients with Parkinson\u2019s disease. Neurochem Res 2012,37(3),512-515","journal-title":"Neurochem Res"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"18865","DOI":"10.1038\/s41598-019-55479-y","volume":"9","author":"Siitonen A.","year":"2019","unstructured":"Siitonen A.; Kyt\u00f6vuori L.; Nalls M.A.; Gibbs R.; Hernandez D.G.; Ylikotila P.; Peltonen M.; Singleton A.B.; Majamaa K.; Finnish Parkinson\u2019s disease study integrating protein-protein interaction network data with exome sequencing analysis. Sci Rep 2019,9(1),18865","journal-title":"Sci Rep"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"573","DOI":"10.2217\/pgs.15.23","volume":"16","author":"Rieck M.","year":"2015","unstructured":"Rieck M.; Schumacher-Schuh A.F.; Callegari-Jacques S.M.; Altmann V.; Schneider Medeiros M.; Rieder C.R.; Hutz M.H.; Is there a role for ADORA2A polymorphisms in levodopa-induced dyskinesia in Parkinson\u2019s disease patients? Pharmacogenomics 2015,16(6),573-582","journal-title":"Pharmacogenomics"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"676","DOI":"10.3390\/molecules22040676","volume":"22","author":"Stockwell J.","year":"2017","unstructured":"Stockwell J.; Jakova E.; Cayabyab F.S.; Adenosine A1 and A2A receptors in the brain: current research and their role in neurodegeneration. Molecules 2017,22(4),676","journal-title":"Molecules"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"e0161567","DOI":"10.1371\/journal.pone.0161567","volume":"11","author":"Mariani E.","year":"2016","unstructured":"Mariani E.; Frabetti F.; Tarozzi A.; Pelleri M.C.; Pizzetti F.; Casadei R.; Meta-analysis of Parkinson\u2019s disease transcriptome data using TRAM software: whole Substantia Nigra tissue and single dopamine neuron differential gene expression. PLoS One 2016,11(9),e0161567","journal-title":"PLoS One"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00702-018-1903-3","volume":"126","author":"Nagatsu T.","year":"2019","unstructured":"Nagatsu T.; Nakashima A.; Ichinose H.; Kobayashi K.; Human tyrosine hydroxylase in Parkinson\u2019s disease and in related disorders. J Neural Transm (Vienna) 2019,126(4),397-409","journal-title":"J Neural Transm (Vienna)"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"e0160925","DOI":"10.1371\/journal.pone.0160925","volume":"11","author":"Nagle M.W.","year":"2016","unstructured":"Nagle M.W.; Latourelle J.C.; Labadorf A.; Dumitriu A.; Hadzi T.C.; Beach T.G.; Myers R.H.; The 4p16. 3 Parkinson disease risk locus is associated with GAK expression and genes involved with the synaptic vesicle membrane. PLoS One 2016,11(8),e0160925","journal-title":"PLoS One"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","volume":"85","author":"Pickrell A.M.","year":"2015","unstructured":"Pickrell A.M.; Youle R.J.; The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson\u2019s disease. Neuron 2015,85(2),257-273","journal-title":"Neuron"},{"key":"ref=55","author":"Br\u00fcggemann N","unstructured":"Br\u00fcggemann N; Klein C; Parkin type of early-onset Parkinson disease"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1046\/j.1365-2125.2000.00259.x","volume":"50","author":"Forsyth J.T.","year":"2000","unstructured":"Forsyth J.T.; Gr\u00fcnewald R.A.; Rostami-Hodjegan A.; Lennard M.S.; Sagar H.J.; Tucker G.T.; Parkinson\u2019s disease and CYP1A2 activity. Br J Clin Pharmacol 2000,50(4),303-309","journal-title":"Br J Clin Pharmacol"},{"key":"ref=57","author":"K\u00e4llstig E.","year":"2017","unstructured":"K\u00e4llstig E.; Unfolding the role of Ire1 and DNAJB1 in Parkinson\u2019s disease 2017"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/brain\/awh054","volume":"127","author":"Bandopadhyay R.","year":"2004","unstructured":"Bandopadhyay R.; Kingsbury A.E.; Cookson M.R.; Reid A.R.; Evans I.M.; Hope A.D.; Pittman A.M.; Lashley T.; Canet-Aviles R.; Miller D.W.; McLendon C.; Strand C.; Leonard A.J.; Abou-Sleiman P.M.; Healy D.G.; Ariga H.; Wood N.W.; de Silva R.; Revesz T.; Hardy J.A.; Lees A.J.; The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson\u2019s disease. Brain 2004,127(Pt 2),420-430","journal-title":"Brain"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1124\/pr.110.002642","volume":"63","author":"Beaulieu J-M.","year":"2011","unstructured":"Beaulieu J-M.; Gainetdinov R.R.; The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 2011,63(1),182-217","journal-title":"Pharmacol Rev"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"16284","DOI":"10.1523\/JNEUROSCI.2590-10.2010","volume":"30","author":"Black K.J.","year":"2010","unstructured":"Black K.J.; Koller J.M.; Campbell M.C.; Gusnard D.A.; Bandak S.I.; Quantification of indirect pathway inhibition by the adenosine A2a antagonist SYN115 in Parkinson disease. J Neurosci 2010,30(48),16284-16292","journal-title":"J Neurosci"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.procbio.2013.02.030","volume":"48","author":"Wang W.","year":"2013","unstructured":"Wang W.; Computational prediction for the protein interactions of tyrosinase: Protein experimental interactome MAP. Process Biochem 2013,48(4),638-648","journal-title":"Process Biochem"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/bph.12181","volume":"169","author":"Waschek J.A.","year":"2013","unstructured":"Waschek J.A.; VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair. Br J Pharmacol 2013,169(3),512-523","journal-title":"Br J Pharmacol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.ajhg.2011.04.017","volume":"88","author":"Miskinyte S.","year":"2011","unstructured":"Miskinyte S.; Butler M.G.; Herv\u00e9 D.; Sarret C.; Nicolino M.; Petralia J.D.; Bergametti F.; Arnould M.; Pham V.N.; Gore A.V.; Spengos K.; Gazal S.; Woimant F.; Steinberg G.K.; Weinstein B.M.; Tournier-Lasserve E.; Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya. Am J Hum Genet 2011,88(6),718-728","journal-title":"Am J Hum Genet"},{"key":"ref=64","author":"Zhou W.","unstructured":"Zhou W.;  Regulation of tumor necrosis factor-induced cell death and toll-like receptor-mediated activation of macrophages by SPATA2. Available from"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1042\/BJ20121022","volume":"450","author":"Kitaguchi T.","year":"2013","unstructured":"Kitaguchi T.; Oya M.; Wada Y.; Tsuboi T.; Miyawaki A.; Extracellular calcium influx activates adenylate cyclase 1 and potentiates insulin secretion in MIN6 cells. Biochem J 2013,450(2),365-373","journal-title":"Biochem J"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jad.2011.10.030","volume":"136","author":"Shi Y.","year":"2012","unstructured":"Shi Y.; Yuan Y.; Xu Z.; Pu M.; Wang C.; Zhang Y.; Liu Z.; Wang C.; Li L.; Zhang Z.; Genetic variation in the Calcium\/calmodulin-dependent protein Kinase (CaMK) pathway is associated with antidepressant response in females. J Affect Disord 2012,136(3),558-566","journal-title":"J Affect Disord"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.nbd.2016.04.008","volume":"93","author":"Gordon R.","year":"2016","unstructured":"Gordon R.; Singh N.; Lawana V.; Ghosh A.; Harischandra D.S.; Jin H.; Hogan C.; Sarkar S.; Rokad D.; Panicker N.; Anantharam V.; Kanthasamy A.G.; Kanthasamy A.; Protein kinase C\u03b4 upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson\u2019s disease. Neurobiol Dis 2016,93,96-114","journal-title":"Neurobiol Dis"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.4161\/auto.25239","volume":"9","author":"Patergnani S.","year":"2013","unstructured":"Patergnani S.; Marchi S.; Rimessi A.; Bonora M.; Giorgi C.; Mehta K.D.; Pinton P.; PRKCB\/protein kinase C, beta and the mitochondrial axis as key regulators of autophagy. Autophagy 2013,9(9),1367-1385","journal-title":"Autophagy"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrm906","volume":"3","author":"Gallo K.A.","year":"2002","unstructured":"Gallo K.A.; Johnson G.L.; Mixed-lineage kinase control of JNK and p38 MAPK pathways. Nat Rev Mol Cell Biol 2002,3(9),663-672","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"543","DOI":"10.2174\/1389202914666131210211033","volume":"14","author":"Gaweda-Walerych K.","year":"2013","unstructured":"Gaweda-Walerych K.; Zekanowski C.; The impact of mitochondrial DNA and nuclear genes related to mitochondrial functioning on the risk of Parkinson\u2019s disease. Curr Genomics 2013,14(8),543-559","journal-title":"Curr Genomics"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/15548627.2015.1121360","volume":"12","author":"Cai Y.","year":"2016","unstructured":"Cai Y.; Arikkath J.; Yang L.; Guo M.L.; Periyasamy P.; Buch S.; Interplay of endoplasmic reticulum stress and autophagy in neurodegenerative disorders. Autophagy 2016,12(2),225-244","journal-title":"Autophagy"},{"key":"ref=72","first-page":"590","volume":"33","author":"Goldenberg M.M.","year":"2008","unstructured":"Goldenberg M.M.; Medical management of Parkinson\u2019s disease. P 2008,33(10),590-606","journal-title":"P"},{"key":"ref=73","unstructured":"National Institute of Neurological Disorders. Parkinson's disease: Hope through research National Institute of Neurological Disorders and Stroke, National Institutes of Health 1994. Available from"},{"key":"ref=74","first-page":"1","volume":"1","author":"Lloret S.P.","year":"2013","unstructured":"Lloret S.P.; Rey M.V.; Rascol O.; Ayurveda medicine for the treatment of Parkinson\u2019s Disease. Int. IntegrativeMed 2013,1,1-6","journal-title":"IntegrativeMed"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.conb.2003.11.001","volume":"13","author":"Benabid A.L.","year":"2003","unstructured":"Benabid A.L.; Deep brain stimulation for Parkinson\u2019s disease. Curr Opin Neurobiol 2003,13(6),696-706","journal-title":"Curr Opin Neurobiol"}],"container-title":["CNS &amp; Neurological Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/185605","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/185605\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/185605","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,5]],"date-time":"2021-12-05T09:28:47Z","timestamp":1638696527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/185605\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,27]]},"references-count":75,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,1,27]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871527319666200905115548","relation":{},"ISSN":["1871-5273"],"issn-type":[{"value":"1871-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1,27]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-04-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-19","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}